Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in us market

Cipla Gets USFDA Nod For Inhalation Product

Brovana is used in maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Read More

ZEE5 To Be Launched In US On June 22

'This direct-to-consumer service launch is especially significant at a time when Indians in the US, many of whom remain deeply connected to their roots, are unable to travel home,

Read More

Lupin Launches Generic Inhalation Product In US Market

Shares of Lupin were trading 0.39 per cent up at Rs 1,237.20 apiece on the BSE.

Read More

Glenmark Pharma Launches Anti-Epileptic Drug In US

Banzel tablets are used in combination with other medications to treat children with Lennox-Gastaut syndrome, a severe form of childhood epilepsy that also causes developmental and behavior problems.

Read More

Dr Reddy's Launches Generic Drug In US Market

The Albenza brand and generics had sales of around USD 27 million in the US for the most recent twelve months ending in November 2020.

Read More

Sun Pharma, Alembic Recall Products In The US Market

Princeton (New Jersey) based Sun Pharmaceutical Industries Inc is also recalling 2,520 bottles of diabetes drug, Metformin HCl Extended-Release tablets, in the US market.

Read More

Dr Reddys Labs Launches Tecfidera Generic In US Market

The company's product is a therapeutic equivalent generic version of Biogen's Tecfidera delayed-release capsules, the Hyderabad-based drug firm said in a statement.

Read More

Lupin Second-Quarter Profit Dives As U.S. Sales, Higher Expenses Weigh

Lupin's sales in North America, which accounts for nearly a third of total sales, dropped 8.3 percent to 12.49 billion rupees ($169.06 million). Income from operations rose marginally to 38.91 billion rupees

Read More

Going Beyond Generics

The generic business for Indian pharma companies has become very large, but now the industry is going through a series of challenges

Read More

Sun Pharma Bets On New Products To Boost US Skincare Products Growth

Sun Pharmaceutical Industries is banking on the launch of newer and more complex products to offset rising competition in its lucrative US dermatology business

Read More